Roundtable - ESG and sustainable innovation: why is this the only way up for an enhanced performance?

Roundtable - ESG and sustainable innovation: why is this the only way up for an enhanced performance?

Thursday, December 9, 2021 2:00 PM to 3:05 PM · 1 hr. 5 min. (Africa/Abidjan)
Roundtable will open Thursday, December 9, 2021 2:00 PM
This roundtable has ended.

Information

“Innovate or die”: is the answer to this recurring question compatible with sustainable development goals? Why and how a well-defined WHY of any company, especially in Life Sciences, can change the key performance indicators and go beyond the usual financial indicators?

During this roundtable, Fabien Mathieu, Partner and Managing Director at Ayming France and co-author of the Ayming Institute book “Profit & Planet, how innovation can help build a better world”, will share his views about how ESG and sustainable innovation are actionable levers to improve business performance of any company in the current circumstances.

The 30-minute lecture, illustrated with inspiring examples taken from our experience with biotechs and pharmaceutical industries, will be followed by a 15-minute debate.


Speaker: Fabien Mathieu, Partner & Managing Director France - Ayming

AymingAyming is a consultancy firm specialized in improving business performance. With presence in 15 countries, Ayming teams are able to support biotech companies in their international and local R&D funding strategies and secure their R&D tax credits, innovation income tax deductions -where applies-, but also European, national and regional grants.   Ayming Belgium places services at the disposal of the BioWin ecosystem to accelerate and anticipate the development of their organization by identifying all the public funding available in the administrative jungle, and then proceeding to implement it in a concrete, operational and secure manner on behalf of companies that might not benefit from them otherwise, lacking the required knowledge or expertise.  Find out more about our international R&D tax credit benchmark 2021  including 15 countries and the R&D funding trends in our International Innovation Barometer 2022.

Registered attendees

BR
Baudouin Regout
BD
Benoit Debande
Chief Administrative and Financial OfficerGroupe Hospitalier Chirec
Vinciane Gaussin
Vinciane Gaussin
Managing DirectorWELBIO

Log in

See all the content and easy-to-use features by logging in or registering!